Stimulant-addicted patients can quit smoking without hindering treatment

Stimulant-addicted patients can quit smoking without hindering treatment

Smokers who are addicted to cocaine or methamphetamine can quit smoking while being treated for their stimulant addiction, without interfering with stimulant addiction treatment. This is according to new research funded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health.

According to the Substance Abuse and Mental Health Services Administration , in 2008, 63 percent of people who had a substance use disorder in the past year also reported current tobacco use, compared to 28 percent of the general population. In fact, tobacco causes more deaths among patients in substance abuse treatment than the substance that brought them to treatment. Despite this, most substance abuse treatment programs do not address .

"Substance abuse treatment programs have historically been hesitant to incorporate concurrent smoking cessation therapies with standard drug addiction treatment because of the concern that patients would drop out of treatment entirely," said NIDA Director Dr. Nora D. Volkow. "However, treating their tobacco addiction may not only reduce the negative health consequences associated with smoking, but could also potentially improve substance use disorder treatment outcomes."

In this study, published today in the Journal of Clinical Psychiatry, some cocaine and/or methamphetamine-dependent patients in were randomly assigned to also receive smoking cessation treatment. Treatment included weekly counseling sessions and extended-release bupropion during weeks one through 10; and a nicotine inhaler and contingency management, which awards prizes to encourage smoking cessation, during weeks four through 10. Outcomes were measured by drug and carbon monoxide testing, and by self-report during the 10-week trial and at a three- and six-month follow-up. Results showed that smoking cessation therapy significantly increased smoking quit rates—both during treatment and at follow-up—without negatively affecting participation in stimulant .

"These findings, coupled with past research, should reassure clinicians that providing smoking-cessation treatment in conjunction with treatment for other will be beneficial to their patients," said Dr. Theresa Winhusen, from the University of Cincinnati College of Medicine and first author on the study.

More information: For a copy of the article by Winhusen et al., go to www.psychiatrist.com/privatepd… 3m08449/13m08449.htm External Web Site Policy.

add to favorites email to friend print save as pdf

Related Stories

Varenicline helps smokers with depression to quit smoking

Sep 16, 2013

About half of smokers seeking treatment for smoking cessation have a history of depression. Compared with smokers who are not depressed, those who suffer from a major depressive disorder (MDD) have greater difficulty quitting.

Recommended for you

Study confirms breast cancer link to low alcohol use

Sep 26, 2014

A newly published study from the University of Victoria's Centre for Addictions Research of BC (CARBC) confirms that moderate drinkers have an increased risk of breast cancer. The study shows that consuming an average of ...

Not all Hispanics are the same when it comes to drinking

Sep 25, 2014

Hispanics are often grouped into a single category when it comes to alcohol use. Yet a new Michigan State University study indicates that the risk of alcohol abuse and dependence can vary significantly among different subgroups ...

Researchers find NAS treatment needs standardization

Sep 25, 2014

When it comes to treating infants with neonatal abstinence syndrome (NAS), researchers from Boston University School of Medicine (BUSM) believe the care for these infants should be consistent and objective, with standardized ...

User comments